
Results
46
High return on equity, past performance and sound balance sheet.
46 companies
Limbach Holdings
Market Cap: US$976.8m
Operates as a building systems solution company in the United States.
LMB
US$84.01
7D
-2.3%
1Y
-14.0%
Harmony Biosciences Holdings
Market Cap: US$2.1b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$36.41
7D
-1.2%
1Y
-6.1%
Global Industrial
Market Cap: US$1.3b
Through its subsidiaries, operates as an industrial distributor of various industrial and maintenance, repair, and operation (MRO) products in the United States and Canada.
GIC
US$32.20
7D
5.3%
1Y
33.8%
Applied Industrial Technologies
Market Cap: US$10.8b
Distributes industrial motion, power, control, and automation technology solutions in the United States, Canada, Mexico, Australia, New Zealand, Singapore, and Costa Rica.
AIT
US$287.03
7D
10.6%
1Y
7.2%
Pegasystems
Market Cap: US$6.7b
Develops, markets, licenses, hosts, and supports enterprise software in the United States, rest of the Americas, the United Kingdom, rest of Europe, the Middle East, Africa, and the Asia-Pacific.
PEGA
US$38.20
7D
-14.4%
1Y
-27.4%
Vita Coco Company
Market Cap: US$3.2b
Develops, markets, and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, Africa, and the Asia Pacific.
COCO
US$56.99
7D
6.8%
1Y
51.8%
Market Cap: US$13.4b
Operates as a visual search and discovery platform in the United States, Canada, Europe, and internationally.
PINS
US$19.32
7D
-13.6%
1Y
-42.5%
ResMed
Market Cap: US$38.3b
Develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.
RMD
US$267.05
7D
3.7%
1Y
12.6%
Stride
Market Cap: US$3.6b
Provides proprietary and third-party online curriculum, software systems, and educational services in the United States and internationally.
LRN
US$86.43
7D
2.8%
1Y
-37.9%
ACADIA Pharmaceuticals
Market Cap: US$4.1b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$23.46
7D
-8.7%
1Y
22.6%